Could managing cholesterol prevent Alzheimer's?

ANA SANDOIU | November 22, 2018

article image
The largest genetic study of Alzheimer's disease to date finds that a "handful of gene variants" increases some people's risk of both dementia and cardiovascular disease. The findings imply that, in principle, we may be able to repurpose some cardiovascular drugs to prevent or treat Alzheimer's.

Spotlight

AllMed Healthcare Management

AllMed Healthcare Management is an independent review organization providing comprehensive physician review solutions to payer and provider organizations nationwide. Our clients include leading health plans, medical management organizations, TPAs, disability carriers, hospital groups and ambulatory surgery centers. Services are deployed through PeerPoint, AllMed's state-of-the-art medical review portal.

OTHER ARTICLES

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 6, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

A pharma outsourcing mission

Article | August 18, 2021

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

The Future of Pharma Beyond Blockbusters

Article | March 17, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

Spotlight

AllMed Healthcare Management

AllMed Healthcare Management is an independent review organization providing comprehensive physician review solutions to payer and provider organizations nationwide. Our clients include leading health plans, medical management organizations, TPAs, disability carriers, hospital groups and ambulatory surgery centers. Services are deployed through PeerPoint, AllMed's state-of-the-art medical review portal.

Events